Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 54
1.
Neuropathology ; 43(6): 486-495, 2023 Dec.
Article En | MEDLINE | ID: mdl-37253452

The typical clinical manifestations of sporadic Creutzfeldt-Jakob disease (sCJD) are rapid-progressive dementia and myoclonus. However, the diagnosis of atypical sCJD can be challenging due to its wide phenotypic variations. We report an autopsy case of variably protease-sensitive prionopathy (VPSPr) with Met/Met homogeneity at codon 129. An 81-year-old woman presented with memory loss without motor symptoms. Seventeen months after the onset, her spontaneous language production almost disappeared. Diffusion-weighted images (DWI) showed hyperintensity in the cerebral cortex while electroencephalogram (EEG) showed nonspecific change. 14-3-3 protein and real-time qualing-induced conversion (RT-QuIC) of cerebrospinal fluid were negative. She died at age 85, 3.5 years after the onset. Pathological investigation revealed spongiform change, severe neuronal loss, and gliosis in the cerebral cortex. Mild to moderate neuronal loss and gliosis were observed in the basal ganglia. PrP immunostaining revealed plaque-like, dotlike, and synaptic structures in the cerebral cortex and small plaque-like structures in the molecular layer of the cerebellum. Analysis of PRNP showed no pathogenic mutations, and Western blot examination revealed the lack of a diglycosylated band consistent with VPSPr. The present case, which is the first report on a VPSPr case in Japan, supports previously published evidence that VPSPr cases can present variable and nonspecific clinical presentations. Because a small number of VPSPr cases can show typical magnetic resonance imaging (MRI) change in sCJD. We should investigate the possibility of VPSPr in a differential diagnosis with atypical dementia that presented DWIs of high intensity in the cortex, even though 14-3-3 proteins and RT-QuIC are both negative. In addition, VPSPr cases can take a longer clinical course compared to that of sCJD, and long-term follow-up is important.


Creutzfeldt-Jakob Syndrome , Prion Diseases , Humans , Aged, 80 and over , Autopsy , Gliosis/pathology , Prion Diseases/pathology , Creutzfeldt-Jakob Syndrome/pathology , Peptide Hydrolases/genetics , Peptide Hydrolases/metabolism , Codon/metabolism , Brain/pathology
2.
Neuropathology ; 42(5): 379-393, 2022 Oct.
Article En | MEDLINE | ID: mdl-35859519

Spinocerebellar degenerations (SCDs) are a diverse group of rare and slowly progressive neurological diseases that include spinocerebellar ataxia type 1 (SCA1), SCA2, SCA3, SCA6, SCA7, dentatorubral-pallidoluysian atrophy (DRPLA) and multiple system atrophy (MSA). They are often inherited, and affect the cerebellum and related pathways. The combination of clinical findings and lesion distribution has been the gold-standard for classifying SCDs. This conventional approach has not been very successful in providing a solid framework shared among researchers because their points of views have been quite variable. After identification of genetic abnormalities, classification was overwhelmed by genotyping, replacing the conventional approach far behind. In this review, we describe a stepwise operational approach that we constructed based only on macroscopic findings without microscopy to classify SCDs into three major groups: pure cerebellar type for SCA6 and SCA31; olivopontocerebellar (OPC) type for SCA1, SCA2, SCA7 and MSA; and dentatorubral-pallidoluysian (DRPL) type for SCA1, SCA3, DRPLA and progressive supranuclear palsy (PSP). Spinocerebellar tract involvement distinguishes SCA1 and SCA3 from DRPLA. Degeneration of the internal segment of the pallidum is accentuated in SCA3 and PSP, while degeneration of the external segment is accentuated in SCA1 and DRPLA. These contrasts are helpful in subdividing OPC and DRPL types to predict their genotypes. Lesion distribution represents disease-specific selective vulnerability, which is readily differentiated macroscopically using our stepwise operational approach. Precise prediction of the major genotypes will provide a basis to understand how genetic abnormalities lead to corresponding phenotypes through disease-specific selective vulnerabilities.


Spinocerebellar Ataxias , Spinocerebellar Degenerations , Humans , Spinocerebellar Ataxias/genetics , Spinocerebellar Degenerations/pathology
3.
J Neuropathol Exp Neurol ; 81(7): 535-544, 2022 06 20.
Article En | MEDLINE | ID: mdl-35511239

Spinocerebellar ataxia type 2 (SCA2) is caused by mutations in the ATXN2 gene in which toxic effects are triggered by expanded polyglutamine repeats within ataxin-2. SCA2 is accompanied by motor neuron degeneration as occurs in amyotrophic lateral sclerosis (ALS). We investigated the distribution patterns of ataxin-2 and transactivation-responsive DNA-binding protein 43 (TDP-43), a major disease-related protein in ALS, in the CNS of 3 SCA2 patients. Phosphorylated TDP-43 (pTDP-43)-positive lesions were widely distributed throughout the CNS and generally overlapped with 1C2 (expanded polyglutamine)-immunoreactive lesions. This distribution pattern is different from the pattern in limbic-predominant age-related TDP-43 encephalopathy. In SCA2, double immunostaining of TDP-43 and 1C2 in motor neurons revealed 3 staining patterns: cytoplasmic 1C2 and nuclear TDP-43, nucleocytoplasmic 1C2 and nuclear TDP-43, and nuclear 1C2 and cytoplasmic TDP-43, which reflect the early, active, and final stages of pathological change, respectively. The translocation of TDP-43 from the nucleus to the cytoplasm along with the translocation of 1C2 in the opposite direction indicates that nuclear accumulation of the disease-specific protein ataxin-2 affects the intracellular dynamics of TDP-43. Such a close interrelationship between mutant ataxin-2 and TDP-43 in the cell might account for the similarity of their distribution in the CNS of patients with SCA2.


DNA-Binding Proteins/metabolism , Spinocerebellar Ataxias , Ataxin-2/genetics , Ataxin-2/metabolism , Brain/pathology , DNA-Binding Proteins/genetics , Humans , Peptides , Spinocerebellar Ataxias/genetics , Spinocerebellar Ataxias/pathology , Transcriptional Activation/genetics
4.
Anat Rec (Hoboken) ; 304(3): 625-630, 2021 03.
Article En | MEDLINE | ID: mdl-33190363

In neuroanatomy textbooks on humans, the posterior median septum is commonly depicted along the midline of the posterior column of the spinal cord. For intramedullary spinal cord tumors, the standard surgical treatment is posterior midline myelotomy. However, its anatomical basis is still unclear. Therefore, in this study we focused on the ultrastructural characterization of the median structure of the posterior column in an adult rat. In the median part of the fasciculi gracilis, a fine lineal tissue continued from the posterior median sulcus to the 3/4th depth of the fasciculi. At higher magnification, this fine lineal tissue consisted of bundles of astrocytes, which are often disrupted and eventually disappeared. At the junction of the ventral part of the fasciculi cuneatus and the gray commissure, short lineal figures of glial tissues extended dorsally. These lineal figures of glial tissues were morphologically similar to other lineal figures of glial tissues found in the posterior column; bundles of astrocytes extending along the axons that entered the gray commissure and the perivascular lineal figures of glial tissues. In conclusion, this study revealed that the posterior median septum is composed of very fine lineal figures of glial tissues that are often disrupted and eventually disappear. We consider these basic structures to be similar in humans. Therefore, during posterior midline myelotomy, accurately separating along the posterior median septum in the posterior column is extremely difficult.


Neuroglia/ultrastructure , Pia Mater/ultrastructure , Spinal Cord/ultrastructure , Animals , Axons/ultrastructure , Male , Microscopy, Electron , Rats , Rats, Wistar
5.
Acta Neuropathol Commun ; 5(1): 19, 2017 03 08.
Article En | MEDLINE | ID: mdl-28274274

We previously reported transcriptional repression-induced atypical cell death of neuron (TRIAD), a new type of necrosis that is mainly regulated by Hippo pathway signaling and distinct from necroptosis regulated by RIP1/3 pathway. Here, we examined the ultrastructural and biochemical features of neuronal cell death in the brains of human HD patients in parallel with the similar analyses using mutant Htt-knock-in (Htt-KI) mice. LATS1 kinase, the critical regulator and marker of TRIAD, is actually activated in cortical neurons of postmortem human HD and of Htt-KI mouse brains, while apoptosis promoter kinase Plk1 was inactivated in human HD brains. Expression levels of YAP/YAPdeltaC were decreased in cortical neurons of human HD brains. Ultra-structural analyses revealed extreme enlargement of endoplasmic reticulum (ER), which characterizes TRIAD, in cortical neurons of human HD and those of Htt-KI mice. These biochemical and morphological results support that TRIAD occurs in human and mouse neurons under the HD pathology.


Huntington Disease/metabolism , Huntington Disease/pathology , Necrosis/metabolism , Necrosis/pathology , Neurons/metabolism , Neurons/ultrastructure , Adaptor Proteins, Signal Transducing/metabolism , Animals , Apoptosis/physiology , Brain/metabolism , Brain/ultrastructure , Cell Cycle Proteins/metabolism , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum/ultrastructure , Gene Knock-In Techniques , Humans , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Transgenic , Phosphoproteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Transcription Factors , YAP-Signaling Proteins , Polo-Like Kinase 1
6.
J Biomed Mater Res A ; 105(1): 8-14, 2017 01.
Article En | MEDLINE | ID: mdl-27529414

We developed a new scaffold material-oriented collagen tubes (OCT)-and evaluated the potential of OCTs combined with basic fibroblast growth factor (bFGF) to repair of a 15 mm sciatic nerve defect in rats. The treatment groups consisted of OCT with adsorbed bFGF (OCT/bFGF group), OCT in phosphate-buffered saline (PBS) (OCT/PBS group), and a no-treatment group (Defect group). Functional evaluation of nerve regeneration was performed using the CatWalk system, and histological analyses of the defect sites were also performed. In rats treated with either OCT/bFGF or OCT/PBS, the walking function parameter of max contact area returned to normal levels by 4 weeks after grafting, and the regeneration of myelinated fibers was detected after 8 weeks. However, more regenerated myelinated fibers were observed in the OCT/bFGF group compared with the OCT/PBS group at 4 weeks. In addition, the max contact area and swing speed in the OCT/bFGF group were significantly recovered compared to the OCT/PBS and Defect groups at 8 weeks. Although the combination of bFGF and OCT was superior to OCT alone for nerve regeneration and functional recovery, the present findings demonstrate that OCT alone or in combination with bFGF accelerates nerve repair in a large peripheral nerve defect in rats. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 8-14, 2017.


Collagen , Fibroblast Growth Factor 2 , Nerve Regeneration/drug effects , Sciatic Nerve/injuries , Sciatic Nerve/physiology , Tissue Scaffolds/chemistry , Animals , Collagen/chemistry , Collagen/pharmacology , Disease Models, Animal , Fibroblast Growth Factor 2/chemistry , Fibroblast Growth Factor 2/pharmacology , Male , Rats , Rats, Sprague-Dawley
7.
Neuropathology ; 35(6): 529-37, 2015 Dec.
Article En | MEDLINE | ID: mdl-26087043

Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder, characterized by formation of multifocal bone cysts and development of leukoencephalopathy, caused by genetic mutations of either DNAX-activation protein 12 (DAP12) or triggering receptor expressed on myeloid cells 2 (TREM2). Although increasing evidence suggests a defect in microglial TREM2/DAP12 function in NHD, the molecular mechanism underlying leukoencephalopathy with relevance to microglial dysfunction remains unknown. TREM2, by transmitting signals via the immunoreceptor tyrosine-based activation motif (ITAM) of DAP12, stimulates phagocytic activity of microglia, and ITAM signaling is counterbalanced by sialic acid-binding immunoglobulin (Ig)-like lectins (Siglecs)-mediated immunoreceptor tyrosine-based inhibitory motif (ITIM) signaling. To investigate a role of CD33, a member of the Siglecs family acting as a negative regulator of microglia activation, in the pathology of NHD, we studied CD33 expression patterns in five NHD brains and 11 controls by immunohistochemistry. In NHD brains, CD33 was identified exclusively on ramified and amoeboid microglia accumulated in demyelinated white matter lesions but not expressed in astrocytes, oligodendrocytes, or neurons. However, the number of CD33-immunoreactive microglia showed great variability from case to case and from lesion to lesion without significant differences between NHD and control brains. These results do not support the view that CD33-expressing microglia play a central role in the development of leukoencephalopathy in NHD brains.


Lipodystrophy/metabolism , Lipodystrophy/pathology , Microglia/metabolism , Microglia/pathology , Osteochondrodysplasias/metabolism , Osteochondrodysplasias/pathology , Sialic Acid Binding Ig-like Lectin 3/biosynthesis , Subacute Sclerosing Panencephalitis/metabolism , Subacute Sclerosing Panencephalitis/pathology , Blotting, Western , Female , Humans , Immunohistochemistry , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction , Sialic Acid Binding Ig-like Lectin 3/analysis
8.
Acta Neurochir (Wien) ; 157(2): 293-8, 2015 Feb.
Article En | MEDLINE | ID: mdl-25503297

BACKGROUND: The pathological characteristics of cyst development after gamma knife surgery (GKS) for arteriovenous malformation (AVM) were analysed. METHOD: Sixteen male and 12 female patients aged 17-67 years (mean 31.3 years) were retrospectively identified among 868 patients who underwent GKS for AVM at our hospital. The pathological characteristics of the reddish nodular lesion and chronic encapsulated expanding haematoma associated with cyst following GKS for AVM were examined. RESULTS: Cyst was associated with chronic encapsulated expanding haematoma in 13, and with nodular lesion in 12 patients. The nidus volume at GKS was 0.1-36 ml (median 6.0 ml), and the prescription dose at the nidus margin was 18-25 Gy (median 20 Gy). Cyst formation was detected from 1.1 to 16 years (mean 7.3 years) after GKS. Seven of the 12 patients with nodular lesion underwent surgery. Ten of the 13 patients with expanding haematoma underwent surgical removal of expanding haematoma. Histological examination was possible in 17 cases. Dilated capillary vessels with wall damage such as hyalinisation and fibrinoid necrosis, marked protein exudation and haemorrhage were the most common findings. Brain parenchyma was observed among the dilated vessels in some cases. Structureless necrotic tissue was not evident. CONCLUSIONS: The present study suggests that enhanced nodular lesion on magnetic resonance imaging and chronic encapsulated expanding haematoma associated with cyst may have common aetiopathology caused by late radiation effects, mainly consisting of dilated capillary vessels with wall damage. Massive protein exudation from such damaged capillary vessels is important in cyst development.


Arteriovenous Fistula/surgery , Cysts/etiology , Cysts/pathology , Intracranial Arteriovenous Malformations/surgery , Radiation Injuries/pathology , Radiosurgery/adverse effects , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Radiosurgery/methods , Young Adult
10.
Orphanet J Rare Dis ; 9: 68, 2014 May 01.
Article En | MEDLINE | ID: mdl-24886140

BACKGROUND: Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder characterized by sclerosing leukoencephalopathy and multifocal bone cysts, caused by a loss-of-function mutation of either DAP12 or TREM2. TREM2 and DAP12 constitute a receptor/adaptor signaling complex expressed exclusively on osteoclasts, dendritic cells, macrophages, and microglia. Neuropathologically, NHD exhibits profound loss of myelin and accumulation of axonal spheroids, accompanied by intense gliosis accentuated in the white matter of the frontal and temporal lobes. At present, the molecular mechanism responsible for development of leukoencephalopathy in NHD brains remains totally unknown. METHODS: By immunohistochemistry, we studied the expression of microtubule-associated protein 1 light chain 3 (LC3), an autophagosome marker, in 5 NHD and 12 control brains. RESULTS: In all NHD brains, Nogo-A-positive, CNPase-positive oligodendrocytes surviving in the non-demyelinated white matter intensely expressed LC3. They also expressed ubiquitin, ubiquilin-1, and histone deacetylase 6 (HDAC6) but did not express Beclin 1 or sequestosome 1 (p62). Substantial numbers of axonal spheroids were also labeled with LC3 in NHD brains. In contrast, none of oligodendrocytes expressed LC3 in control brains. Furthermore, surviving oligodendrocytes located at the demyelinated lesion edge of multiple sclerosis (MS) did not express LC3, whereas infiltrating Iba1-positive macrophages and microglia intensely expressed LC3 in MS lesions. CONCLUSIONS: These results propose a novel hypothesis that aberrant regulation of autophagy might induce oligodendrogliopathy causative of leukoencephalopathy in NHD brains.


Biomarkers/metabolism , Brain/metabolism , Lipodystrophy/metabolism , Microtubule-Associated Proteins/metabolism , Oligodendroglia/metabolism , Osteochondrodysplasias/metabolism , Phagosomes/metabolism , Subacute Sclerosing Panencephalitis/metabolism , Adult , Aged , Case-Control Studies , Female , Humans , Male , Middle Aged
11.
Brain Pathol ; 24(6): 599-606, 2014 Nov.
Article En | MEDLINE | ID: mdl-24674145

Spinocerebellar ataxia type 2 (SCA2) is a hereditary neurodegenerative disorder caused by the expansion of the trinucleotide CAG repeats encoding elongated polyglutamine tract in ataxin-2, the SCA2 gene product. Polyglutamine diseases comprise nine genetic entities, including seven different forms of spinocerebellar ataxias, Huntington's disease, and spinal and bulbar muscular atrophy. These are pathologically characterized by neuronal loss and intranuclear aggregates or inclusions of mutant proteins including expanded polyglutamine in selected neuronal groups. Previously, we examined immunolocalization of ubiquitin, expanded polyglutamine (probed by 1C2 antibody), and ataxin-2 in genetically confirmed SCA2 patients. In the present study, we expanded this approach by distinguishing different patterns of subcellular 1C2 immunoreactivity ("granular cytoplasmic," "cytoplasmic and nuclear" and "nuclear with inclusions.") and by quantifying their regional frequencies in three autopsied SCA2 brains at different stage of the disease. Comparison with neuronal loss and gliosis revealed that overall 1C2 immunoreactivity was paralleled with their severity. Furthermore, appearance of granular cytoplasmic pattern corresponded to early stage, cytoplasmic and nuclear pattern to active stage, and nuclear with inclusions pattern to final stage. We conclude that this 1C2-immunoreactive typing may be useful for evaluating the overall severity and extent of affected regions and estimating the neuropathological stage of SCA2.


Brain/physiopathology , Cell Nucleus/metabolism , Cytoplasm/metabolism , Neurons/physiology , Spinocerebellar Ataxias/physiopathology , Adult , Aged , Aged, 80 and over , Ataxins , Atrophy , Brain/pathology , Cell Nucleus/pathology , Cytoplasm/pathology , Disease Progression , Female , Gliosis/pathology , Gliosis/physiopathology , Humans , Immunohistochemistry , Intranuclear Inclusion Bodies/metabolism , Intranuclear Inclusion Bodies/pathology , Male , Middle Aged , Nerve Tissue Proteins/metabolism , Neurons/pathology , Peptides/metabolism , Spinocerebellar Ataxias/pathology , Ubiquitin/metabolism
12.
Neuropathology ; 34(1): 27-31, 2014 Feb.
Article En | MEDLINE | ID: mdl-23711133

It has been reported that abnormal processing of pre-mRNA is caused by abnormal triplet expansion. Non-coding triplet expansions produce toxic RNA to alter RNA splicing activities. However, there has been no report on the globular RNA aggregation in neuronal cytoplasmic inclusions (NCIs) up to now. We herein report on an autopsy case (genetically determined as spinocerebellar atrophy 8 (SCA8)) with hitherto undescribed NCIs throughout the brain. NCIs were chiefly composed of small granular particles, virtually identical to ribosomes. Neurological features are comparable to the widespread lesions of the brain, including the spinal cord. Although 1C2-positivity of NCIs might be induced by reverse transcription of the CTG expansion, it remains to be clarified how abnormal aggregations of ribosome and extensive brain degeneration are related to the reverse or forward transcripts of the expanded repeat.


Inclusion Bodies/ultrastructure , Neurons/ultrastructure , Spinocerebellar Ataxias/pathology , Adult , Cytoplasm/ultrastructure , DNA Repeat Expansion , Humans , Inclusion Bodies/genetics , Male , Spinocerebellar Ataxias/genetics
13.
Neuropathology ; 34(3): 304-8, 2014 Jun.
Article En | MEDLINE | ID: mdl-24354582

Adult-onset GM2 gangliosidosis is very rare and only three autopsy cases have been reported up to now. We report herein an autopsy case of adult-onset GM2 gangliosidosis. The patient developed slowly progressive motor neuron disease-like symptoms after longstanding mood disorder and cognitive dysfunction. He developed gait disturbance and weakness of lower limbs at age 52 years. Because of progressive muscle weakness and atrophy, he became bed-ridden at age 65. At age of 68, he died. His neurological findings presented slight cognitive disturbance, slight manic state, severe muscle weakness, atrophy of four limbs and no extrapyramidal signs and symptoms, and cerebellar ataxia. Neuropathologically, mild neuronal loss and abundant lipid deposits were noted in the neuronal cytoplasm throughout the nervous system, including peripheral autonomic neurons. The most outstanding findings were marked neuronal loss and distended neurons in the anterior horn of the spinal cord, which supports his clinical symptomatology of lower motor neuron disease in this case. The presence of lipofuscin, zebra bodies and membranous cytoplasmic bodies (MCB) and the increase of GM2 ganglioside by biochemistry led to diagnosis of GM2 gangliosidosis.


Gangliosidoses, GM2/complications , Gangliosidoses, GM2/pathology , Motor Neuron Disease/complications , Motor Neuron Disease/pathology , Aged , Autopsy , Diagnosis, Differential , Gangliosidoses, GM2/psychology , Humans , Male , Motor Neuron Disease/psychology
14.
Neuroreport ; 24(11): 620-5, 2013 Aug 07.
Article En | MEDLINE | ID: mdl-23778076

Non-cell-autonomous pathology involving glial cells has been implicated in Purkinje cell degeneration. We reported previously that mutant ataxin-1, a causative gene product of spinocerebellar ataxia type 1 (SCA1), prevents Bergmann glia proliferation in mutant ataxin-1 knockin mice and that suppressed Bergmann glia function leads to Purkinje cell degeneration. However, because reactive astrocytes are produced in response to brain injuries and diseases, Bergmann glia are also suspected to proliferate and increase in response to Purkinje cell degeneration, including during SCA1 pathogenesis. However, little is known about reactive Bergmann glia (Bergmann gliosis) and its beneficial or detrimental role. Given the lack of quantitative studies of Bergmann glia using specific molecular markers, we quantified Bergmann glia in human SCA1 brains with Bergmann glia-specific Sox2 staining and conventional hematoxylin and eosin staining. Our results showed reduced numbers of Bergmann glia in SCA1 patient brains and support the hypothesis that Bergmann glia loss contributes toward Purkinje cell degeneration in human SCA1.


Neuroglia/pathology , Spinocerebellar Ataxias/pathology , Humans , Immunohistochemistry
15.
Reg Anesth Pain Med ; 38(2): 140-4, 2013.
Article En | MEDLINE | ID: mdl-23271031

BACKGROUND: Epinephrine can potentially worsen the neurotoxic effects of local anesthetics when used for spinal or epidural anesthesia. The vasoconstrictive property of epinephrine reduces dural blood flow, which in turn reduces the clearance of local anesthetics from the subarachnoid space. This study examined the histological and neurofunctional effects of intrathecally administered lidocaine combined with epinephrine in rats. METHODS: Sixty-two rats were divided into 9 treatment groups: 5% or 7.5% lidocaine in 10% glucose solution with or without 0.1 or 0.5 mg/mL epinephrine, or epinephrine alone at 0.1 or 0.5 mg/mL in 10% glucose, or 10% glucose alone. Hind-limb motor function was evaluated immediately after drug injection by walking behavior. Sensory function was assessed by the response to radiant heat stimulation at just before and 1 week after the injection. Seven days after the injection, L3 spinal cord with anterior and posterior roots, the dorsal ganglion, and cauda equina were harvested and examined histologically. RESULTS: Histological lesions were limited to the posterior root just at entry into the spinal cord in rats injected with 7.5% lidocaine, with and without epinephrine. No histological abnormalities were noted in other areas or other groups. There was no significant change in sensory threshold in all groups. Significantly, prolongation of gait recovery time was noted in 5% and 7.5% lidocaine with epinephrine groups compared with 5% or 7.5% lidocaine alone. CONCLUSIONS: Intrathecal epinephrine prolonged the action of intrathecal lidocaine but did not worsen lidocaine-induced histological damage and functional impairment.


Anesthetics, Local/toxicity , Epinephrine/toxicity , Lidocaine/toxicity , Neurotoxicity Syndromes/etiology , Spinal Cord/drug effects , Vasoconstrictor Agents/toxicity , Anesthetics, Local/administration & dosage , Animals , Behavior, Animal/drug effects , Drug Interactions , Epinephrine/administration & dosage , Injections, Spinal , Lidocaine/administration & dosage , Male , Motor Activity/drug effects , Neurotoxicity Syndromes/pathology , Neurotoxicity Syndromes/physiopathology , Neurotoxicity Syndromes/psychology , Pain Perception/drug effects , Pain Threshold/drug effects , Rats , Rats, Wistar , Recovery of Function , Spinal Cord/pathology , Spinal Cord/physiopathology , Time Factors , Vasoconstrictor Agents/administration & dosage
16.
Parkinsonism Relat Disord ; 18(7): 819-23, 2012 Aug.
Article En | MEDLINE | ID: mdl-22525366

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common cause of autosomal-dominant familial Parkinson's disease (FPD). The variable pathological features of LRRK2-linked FPD include Lewy bodies, degeneration of anterior horn cells associated with axonal spheroids, neurofibrillary tangles (NFTs) and TAR DNA-binding protein of 43 kDa (TDP-43) positive inclusion bodies. Furthermore, abnormal hyperphosphorylation of microtubule associated protein tau, in part generated by catalysis of protein kinases, has been reported to be involved in progressive neurodegeneration in a number of diseases, including FPD. Thus, we examined six patients carrying the LRRK2 I2020T mutation, a pathogenic mutation associated with PARK8, and found abnormal tau phosphorylation depositions in the brainstem. Additionally, we found LRRK2 I2020T enhanced tau phosphorylation in cultured cells co-expressing LRRK2-I2020T and 3 or 4-repeated tau. This is the first report describing the relationship between hyperphosphorylation of tau and LRRK2 I2020T.


Mutation/genetics , Parkinson Disease/genetics , Protein Serine-Threonine Kinases/genetics , tau Proteins/metabolism , Brain Stem/metabolism , Brain Stem/pathology , Female , Humans , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 , Male , Middle Aged , Parkinson Disease/metabolism , Phosphorylation
17.
Can J Anaesth ; 59(5): 456-65, 2012 May.
Article En | MEDLINE | ID: mdl-22383086

PURPOSE: The aim of this study was to compare the neurotoxicity of intrathecal procaine, bupivacaine, levobupivacaine, and ropivacaine in an animal model. METHODS: The study comprised two experiments. In the concentration experiment, rats (n = 78) were administered 0.12 µL·g(-1) body weight (BW) of 2% or 20% procaine, 0.5% or 5% bupivacaine, 0.5% or 5% levobupivacaine, or 0.5% or 5% ropivacaine. Based on the findings, the doses were increased by volume in the subsequent volume experiment using 0.12, 0.24, or 0.48 µL·g(-1) BW of 6% procaine, 6% levobupivacaine, or 6% ropivacaine (n = 79). Walking behaviour and sensory threshold were analyzed, and a histological examination of the spinal cord, posterior and anterior roots, and cauda equina was performed. RESULTS: The concentration experiment showed abnormalities only in the 5% bupivacaine group, and these abnormal findings were in the posterior root (PR) and posterior column (PC). The volume experiment revealed that procaine 0.24 µL·g(-1) was neurotoxic, mainly affecting the PR. At 0.48 µL·g(-1), severe injury was observed in the PR and PC in all six procaine rats and four of six levobupivacaine rats, while milder injury was limited to the PR in one of six ropivacaine rats, which differed significantly from the former two groups (P = 0.006 and P = 0.014, respectively). Electron microscopy showed axonal degeneration. CONCLUSION: All four local anesthetics seemed to cause identical neurotoxic lesions commencing in the PR and extending to the PC by axonal degeneration. Bupivacaine appeared to be the most neurotoxic of the four drugs, and the neurotoxicity at higher doses increased by volume with procaine > levobupivacaine > ropivacaine.


Anesthetics, Local/toxicity , Behavior, Animal/drug effects , Neurotoxicity Syndromes/etiology , Spinal Cord/drug effects , Amides/administration & dosage , Amides/toxicity , Anesthetics, Local/administration & dosage , Animals , Axons/drug effects , Axons/pathology , Bupivacaine/administration & dosage , Bupivacaine/analogs & derivatives , Bupivacaine/toxicity , Dose-Response Relationship, Drug , Injections, Spinal , Levobupivacaine , Male , Microscopy, Electron , Models, Animal , Neurotoxicity Syndromes/physiopathology , Procaine/administration & dosage , Procaine/toxicity , Rats , Rats, Wistar , Ropivacaine , Severity of Illness Index , Spinal Cord/pathology
18.
Neuropathology ; 32(2): 149-57, 2012 Apr.
Article En | MEDLINE | ID: mdl-21981270

Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder, characterized by progressive presenile dementia and formation of multifocal bone cysts, caused by a loss-of-function mutation of DNAX-activation protein 12 (DAP12) or triggering receptor expressed on myeloid cells 2 (TREM2). TREM2 and DAP12 constitute a receptor/adaptor complex on myeloid cells. The post-receptor signals are transmitted via rapid phosphorylation of the immunoreceptor tyrosine-based activating motif (ITAM) of DAP12, mediated by Src protein tyrosine kinases, followed by binding of phosphorylated ITAM to Src homology 2 (SH2) domains of spleen tyrosine kinase (Syk), resulting in autophosphorylation of the activation loop of Syk. To elucidate the molecular mechanism underlying the pathogenesis of NHD, we investigated Syk expression and activation in the frontal cortex and the hippocampus of three NHD and eight control brains by immunohistochemistry. In NHD brains, the majority of neurons expressed intense immunoreactivities for Syk and Y525/Y526-phosphorylated Syk (pSyk) chiefly located in the cytoplasm, while more limited populations of neurons expressed Src. The levels of pSyk expression were elevated significantly in NHD brains compared with control brains. In both NHD and control brains, substantial populations of microglia and macrophages expressed pSyk, while the great majority of reactive astrocytes and myelinating oligodendrocytes did not express pSyk, Syk or Src. These observations indicate that neuronal expression of pSyk was greatly enhanced in the cerebral cortex and the hippocampus of NHD brains, possibly via non-TREM2/DAP12 signaling pathways involved in Syk activation.


Brain/enzymology , Gene Expression Regulation, Enzymologic , Intracellular Signaling Peptides and Proteins/metabolism , Lipodystrophy/enzymology , Osteochondrodysplasias/enzymology , Protein-Tyrosine Kinases/metabolism , Subacute Sclerosing Panencephalitis/enzymology , Up-Regulation/physiology , Adult , Aged , Brain/metabolism , Cerebral Cortex/enzymology , Cerebral Cortex/pathology , Female , Hippocampus/enzymology , Hippocampus/pathology , Humans , Intracellular Signaling Peptides and Proteins/biosynthesis , Lipodystrophy/pathology , Male , Middle Aged , Osteochondrodysplasias/pathology , Phosphorylation/physiology , Protein-Tyrosine Kinases/biosynthesis , Subacute Sclerosing Panencephalitis/pathology , Syk Kinase
19.
No Shinkei Geka ; 39(11): 1067-72, 2011 Nov.
Article Ja | MEDLINE | ID: mdl-22036818

A 34-year-old female presented with an 8-year history of temporal lobe epilepsy. Magnetic resonance imaging showed a multilobular, well-demarcated and homogeneous tumorous lesion of 5 cm in diameter deep in the left sylvian fissure. Intraoperative findings revealed that the tumor was mainly in the left insular region without dural attachment and strongly adhered to the left middle cerebral artery and its perforators. The histopathological diagnosis was transitional meningioma without malignancy. There are few reported cases of deep sylvian meningioma without dural attachment. We review the literature and summarize the clinicopathological characteristics of this condition.


Meningeal Neoplasms/surgery , Meningioma/surgery , Adult , Female , Humans , Meningeal Neoplasms/pathology , Meningioma/pathology
20.
Brain Res ; 1404: 50-4, 2011 Aug 02.
Article En | MEDLINE | ID: mdl-21722877

Astrocytic plaques (APs) and tuft-shaped astrocytes (TAs) are frequently found in the brains of patients with corticobasal degeneration or progressive supranuclear palsy and are considered histopathological markers of these clinicopathological entities. Possible involvement of blood vessels in these lesions, occasionally found in routine histological examination, was estimated by observing thick sections (50-100 µm). The relative distance between the center of each AP/TA to the nearest blood vessel was lesser than that between the nearest blood vessel and control random reference points, and this finding confirmed that APs/TAs are formed in close proximity to blood vessels. Furthermore, three-dimensional reconstruction of sections double-immunolabeled for phosphorylated tau (AT8) and blood vessels (von Willebrand factor) showed the smaller diameter of TAs (mean±SD, 31.3±5.2 µm; n=15) and closer contact of their AT8-positive processes to blood vessels, representing proximal accumulation of phosphorylated tau in TAs. This is in contrast with larger APs (88.5±15.2µm, n=63), in which AT8-positive processes rarely have vascular contact. Even though the endfeet of astrocytes come into close contact with blood vessels, tau deposition, observed in both TAs and APs, was always oriented around the blood vessel, implying that these apparently distinct lesions (APs/TAs) share a common mechanism for tau deposition that is oriented around the blood vessel.


Astrocytes/pathology , Blood Vessels/pathology , Neurofibrillary Tangles/pathology , Plaque, Amyloid/pathology , Aged , Astrocytes/metabolism , Basal Ganglia Diseases/complications , Basal Ganglia Diseases/pathology , Female , Humans , Imaging, Three-Dimensional/methods , Male , Middle Aged , Neurofibrillary Tangles/metabolism , Plaque, Amyloid/etiology , Plaque, Amyloid/metabolism , Supranuclear Palsy, Progressive/complications , Supranuclear Palsy, Progressive/pathology , tau Proteins/metabolism
...